Johnson & Johnson Shares Fall More Than 5% After MedTech Results Miss
Johnson & Johnson shares fell more than 5% Tuesday morning after the company reported weaker-than-expected results from its medical devices division. CFO Joe Wolk said on the earnings call that MedTech performance needs to improve.
Johnson & Johnson shares fell more than 5% Tuesday morning after the company posted weaker-than-expected results in its medical devices division. “We are clear on where MedTech performance needs to improve,” Chief Financial Officer Joe Wolk said on the earnings call, which was cut off in the supplied section.